27 May 2013
: Case report
Adalimumab (Humira) induced acute lung injury
Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy
Ritesh KohliEFG, Karim NamekEFDOI: 10.12659/AJCR.889200
Am J Case Rep 2013; 14:173-175
Abstract
Background: Adalimumab is a recombinant human monoclonal antibody that blocks the effects of tumor necrosis factor-alpha. Adalimumab related acute lung injury is a rare form of acute respiratory distress syndrome of possible immune etiology that develops immediately after an infusion.
Case Report: We describe a 78 year old, male with no previous cardiac comorbidities, who developed acute lung injury (ALI) within one hour of administration of adalimumab. He was successfully treated with mechanical ventilatory support and adjuvant therapy.
Conclusions: TNFalpha antagonists are a part of a new and revolutionary treatment for severe and difficult-to-treat autoimmune and inflammatory diseases.This report emphasizes that this fatal complication may occur with use of this drug.Clinicians need to be aware of this condition as prompt recognition and supportive management can prevent unwanted morbidity and mortality.
Keywords: acute lung injury, adalimumab, Anti-Inflammatory Agents - adverse effects, Respiratory Distress Syndrome, Adult
SARS-CoV-2/COVID-19
21 March 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938730
21 March 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938659
02 April 2023 : Case report
Am J Case Rep 2023; 24:e938732
31 March 2023 : Case report
Am J Case Rep 2023; 24:e938761
In Press
31 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.938131
30 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939200
30 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939365
28 Mar 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939387
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347